SCHEMBL15977809

SCHEMBL15977809

c1ccc(-c2cc(-c3ccccc3)cc(-c3c4ccccc4c(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4cc(-c5ccc(-c6ccccn6)cn5)ccc34)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.43
HPGDS O60760 1/20 0.43
DHODH Q02127 1/20 0.41
PRMT5 O14744 2/20 0.41
WDR77 Q9BQA1 1/20 0.41
AXL P30530 1/20 0.39
KDR P35968 1/20 0.39
METAP2 P50579 1/20 0.38
CNR2 P34972 1/20 0.38
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977596 0.94 CYP2A6 (0.45) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL15977506 0.92 HPGDS (0.46) CYP2A6HPGDSDHODHKDRHSD17B1
SCHEMBL10030108 0.92 CYP2A6 (0.47) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL15306468 0.90 HPGDS (0.47) CYP2A6HPGDSDHODHKDRHSD17B1
SCHEMBL10030102 0.90 CYP2A6 (0.46) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL17342842 0.89 HPGDS (0.46) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL17737597 0.89 HPGDS (0.46) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL23344747 0.88 HPGDS (0.47) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL24106243 0.88 HPGDS (0.47) CYP2A6HPGDSDHODHPRMT5WDR77
SCHEMBL17877067 0.87 DHODH (0.41) CYP2A6DHODHPRMT5WDR77KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP2A6 3184/4885HPGDS 4636/4885DHODH 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.